Our scientific and management team has a vast experience in the pharma industry,essential to fulfill our ambitious goals of developing and marketing patented innovative therapies in the cannabis and medical mushroom arena
Elchanan Shaked | CEO & Chairman
Long-standing experience in executive management, strategy generation, business development, marketing and global networks.
Chairman and main shareholder at STA Asia Holdings, delivering Israeli technologies to emerging markets in agriculture, pharma & medicine.
Co-Founder and former CEO at Natural Formula; and the former CEO of consumer products at Perrigo and Agis Industries
Gadi Klarsfeld | Chief Commercial Officer
Extensive experience in building new business units and companies in the retail, FMCG and medical devices fields.
Owner and CEO of G.K. Consulting, specializing in international consultancy for pharmacy retailers.
Former CEO of Dental View and New Life Drugstores SRL, Health and Beauty division manager in Blue Suqare Israel and franchisee of Super-Pharm Eilat.
Moav Gafni | Business Development
CEO of Ethernal Cannabis Ltd. – the Bussines development arm of Phatebo GmbH – German Medical Cannabis importer and distributor with 25 years experience. Extensive experience in the agronomic aspects of Cannabis Cultivation, Marketing and Regulation.
Prof. Ilan Ron | Chief Clinical Officer
An expert in clinical oncology and radiation. Served as the Chief Physician of the Oncology Department at the Tel Aviv Medical Center – 2019-1994. He serves as Associate Professor in the Department of Oncology at Tel Aviv University and Director of the Research Laboratory for the Development of Cancer Drugs from Natural Materials at Ichilov Medical Center in Tel Aviv. Ron published more than 80 scientific articles in the world’s leading scientific journals and is a member of important Israeli and international oncology associations
Dr. Efrat Oron | Head Of Medical Cannabis
Director of Research and Outreach at the Manna Center for Food safety and security in Tel Aviv University. Food-Tech expert with extensive knowledge of the local and global industry MSc and a PhD in Molecular Biology from Tel-Aviv University, and postdoctoral fellow at Yale University.
Dr. Dov Melamed | CTO
Co-Founder of Periness LTD and Oshadi LTD, Non-Executive Director of XTL Biopharmaceuticals and former president of SciVac.
researcher at Bar-Ilan University’s Male Fertility clinic and QBI.
Demonstrated success in taking drugs from the lab to the shelf by identifying target markets, planning regulatory strategy, raising capital, executing clinical trials and scaling up to commercial production.
Sarel Chen-Tov | Executive Advisor
CEO of Biopharmax Group.
He is an expert in design and construction of API, Pharma and Biotech projects to FDA / EMEA standards and has near 20 years of experience.
Unique expertise in efficient and innovative plant design to suit the business case, optimize Capex and Opex, providing the client a competitive edge in the marketplace.
Prof. Haim Lotan
Director of the cardiology division at Hadassah University Hospital and former president of the Israel Cardiology Association. As a prominent figure in the world of cardiology, Haim founded and directed the Israeli Department of Invasive Cardiology. He has led a large number of clinical studies in the field of cardiology.
Dr. Basem Fares; Medical Cannabis R&D
Holds a Ph.D. in Onchology and Cancer Biology in the Faculty of Medicine in the Technion Institute of Technology. He is a cancer researcher at the Rambam Oncology Department, and was previously a research assistant in Mount Carmel Hospital and in Prulor Biotech
Yoav Rothler | CFO
Long-standing experience in finance, economics and business development. Former Partner in TerraVerde Agriculture Ltd., specializing in the economic planning and implementation of agro-industrial projects around the globe. Researcher in Tel-Aviv University, analyzing agricultural technology adoption in low and middle-income countries.
Prof. Fuad Fares | Head Of Drug R&D
World renowned biologist and pharmaceologist. Founder and director of the Department of Molecular Genetics at Carmel Medical Center, an associate professor in the Department of Human Biology in University of Haifa; Member of the Israel Council for Higher Education. Founder and CTO of Prolor Biotechnology and founder of CanCurX Ltd.